SURVEY OF URINARY ALBUMIN RATE IN PATIENTS WITH HYPERTENSION AND TYPE 2 DIABETES

Trần Thiện Đức 1 , , Nguyễn Văn Bé Hai 1 , Dương Thị Trang 1 , Nguyễn Thị Phương Dung 1 , Nguyễn Thuỳ Dung 1
1 Thong Nhat Hospital image/svg+xml
* Corresponding author:

Article Information

Metrics
Downloads: 1 Views: 8
DOI
10.63947/bvtn.v1i3.15
Published
2025-07-10
Issue Vol. 1 No. 3 (2025): Adapting to the trend of population aging and an aged population
Section
Original Paper
Categories
Research

Download Article

PDF (Vietnamese)

How to Cite

1.
Thiện Đức T, Văn Bé Hai N, Thị Trang D, Thị Phương Dung N, Thuỳ Dung N. SURVEY OF URINARY ALBUMIN RATE IN PATIENTS WITH HYPERTENSION AND TYPE 2 DIABETES. JHA [Internet]. Vietnam; 2025 Jul. 10 [cited 2025 Jul. 21];1(3):104–109. https://tcsuckhoelaohoa.vn/bvtn/article/view/70 doi: 10.63947/bvtn.v1i3.15
Loading citation...
Crossref
Scopus
Google Scholar
Europe PMC

Abstract

Albuminuria is a key marker for early kidney damage and cardiovascular risk in patients with diabetes and hypertension, even when glomerular filtration rate (GFR) is preserved. However, data on the prevalence of albuminuria in Vietnamese populations remains limited. To assess the prevalence of albuminuria and its associated clinical factors in patients with type 2 diabetes and/or hypertension. This cross-sectional study included 209 patients at Thong Nhat Hospital, Ho Chi Minh City. Clinical characteristics, blood pressure control, and laboratory data including urinary albumin-to-creatinine ratio (UACR) were collected. Albuminuria was defined as UACR ≥30 mg/g, including microalbuminuria (30–299 mg/g) and macroalbuminuria (≥300 mg/g). Logistic regression was used to identify factors associated with albuminuria. The mean age was 68.04 ± 13.94 years, and 38.8% had type 2 diabetes. Overall, 27.7% of patients had albuminuria, including 16.7% with microalbuminuria and 11.0% with macroalbuminuria. Blood pressure was controlled in 58.7% of participants. Only 42.5% of diabetic patients achieved glycemic targets. Macroalbuminuria was significantly more common in patients with uncontrolled blood pressure (18.6% vs. 5.7%, p < 0.01). No significant associations were found between albuminuria and age, sex, or ASCVD. Albuminuria is prevalent in patients with diabetes and hypertension, particularly among those with uncontrolled blood pressure. These findings support routine screening for albuminuria and early initiation of renoprotective therapy to prevent renal and cardiovascular complications in high-risk Vietnamese populations.

Keywords

Albuminuria type 2 diabetes mellitus hypertension chronic kidney disease UACR

References

  1. Jager KJ, Kovesdy C, Langham R, Rosenberg M, Jha V, Zoccali C. A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2019;34:1803-5.
  2. Kovesdy CP. Epidemiology of chronic kidney disease: an update 2022. Kidney international supplements. 2022;12:7-11.
  3. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney international. 2024;105:S117-s314.
  4. Barzilay JI, Farag YMK, Durthaler J. Albuminuria: An Underappreciated Risk Factor for Cardiovascular Disease. Journal of the American Heart Association. 2024;13:e030131.
  5. Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet (London, England). 2010;375:2073-81.
  6. Matsushita K, Coresh J, Sang Y, Chalmers J, Fox C, Guallar E, et al. Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data. The lancet Diabetes & endocrinology. 2015;3:514-25.
  7. Shlipak MG, Tummalapalli SL, Boulware LE, Grams ME, Ix JH, Jha V, et al. The case for early identification and intervention of chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney international. 2021;99:34-47.
  8. Shin JI, Chang AR, Grams ME, Coresh J, Ballew SH, Surapaneni A, et al. Albuminuria Testing in Hypertension and Diabetes: An Individual-Participant Data Meta-Analysis in a Global Consortium. Hypertension (Dallas, Tex : 1979). 2021;78:1042-52.
  9. Fici F, Bakir EA, Beyaz S, Makel W, Robles NR. PAIT-survey-Prevalence of albuminuria in patients with diabetes and hypertension in Turkey. Primary care diabetes. 2018;12:558-64.
  10. Lê CT, Trần TTT, Trần TN. TỶ LỆ MICROALBUMIN NIỆU DƯƠNG TÍNH VÀ MỐI LIÊN QUAN GIỮA MICROALBUMIN NIỆU DƯƠNG TÍNH, CHỈ SỐ MICROALBUMIN/ CREATININ Ở MẪU NƯỚC TIỂU NGẪU NHIÊN VỚI MỨC LỌC CẦU THẬN CỦA BỆNH NHÂN ĐÁI THÁO ĐƯỜNG TYPE 2. Tạp chí Y học Việt Nam. 2023;529.
  11. Hường PT, Phương PT, Phúc NQ. Nghiên cứu đặc điểm tổn thương thận ở bệnh nhân đái tháo đường típ 2 phát hiện trong năm đầu. Nội tiết và đái tháo đường. 2023;69.

License

© 2025 The Author(s). Published by Journal of Health and Aging.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.